                         SEQUENCE LISTING

<110>  PROVINCIAL HEALTH SERVICES AUTHORITY ET AL
 
<120>  ANTIMICROBIAL PEPTIDES

<130>  PAT 107205W-90

<140>  PCT/CA2019/051778
<141>  2019-12-10

<150>  US 62/778,450
<151>  2018-12-12

<160>  178   

<170>  PatentIn version 3.5

<210>  1
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimicrobial peptide with reference to North American bullfrog, 
       Rana (Lithobates) catesbeiana

<400>  1

Met Phe Thr Met Lys Lys Ser Leu Leu Leu Leu Phe Phe Leu Gly Thr 
1               5                   10                  15      


Ile Ser Leu Ser Leu Cys Glu Gln Glu Arg Asn Ala Asp Asp Asp Gln 
            20                  25                  30          


Gly Glu Val Ile Glu Gln Lys Val Lys Arg 
        35                  40          


<210>  2
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimicrobial peptide based on North American bullfrog, Rana 
       (Lithobates) catesbeiana

<400>  2

Ala Phe Leu Ser Thr Val Lys Asn Thr Leu Thr Asn Val Ala Gly Thr 
1               5                   10                  15      


Met Ile Asp Thr Phe Lys Cys Lys Ile Thr Gly Val Cys 
            20                  25                  


<210>  3
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimicrobial peptide based on North American bullfrog, Rana 
       (Lithobates) catesbeiana

<400>  3

Val Leu Leu Tyr Leu Ile Ile Thr Val Ser Phe Pro Arg Arg Asp Ala 
1               5                   10                  15      


Asn Asp Glu Asp Gly Gly Glu Val Thr Lys Glu Val Val Lys Arg 
            20                  25                  30      


<210>  4
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimicrobial peptide based on North American bullfrog, Rana 
       (Lithobates) catesbeiana

<400>  4

Ser Leu Ser Gly Cys Trp Thr Lys Ser Phe Pro Arg Lys Pro Cys Leu 
1               5                   10                  15      


Arg Asn Arg 
            


<210>  5
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimicrobial peptide based on North American bullfrog, Rana 
       (Lithobates) catesbeiana

<400>  5

Met Ser Ser Phe Cys Glu Ile Thr Asn Val Ala Leu Thr Ile Ser Leu 
1               5                   10                  15      


Ser Ser Pro Arg Arg Gly Ala Asp Glu Glu Glu Gly Asn Gly Glu Lys 
            20                  25                  30          


Glu Ile Lys Arg 
        35      


<210>  6
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimicrobial peptide based on North American bullfrog, Rana 
       (Lithobates) catesbeiana

<400>  6

Ser Met Leu Ser Val Leu Lys Asn Leu Gly Lys Val Gly Leu Gly Phe 
1               5                   10                  15      


Val Ala Cys Lys Ile Asn Lys Gln Cys 
            20                  25  


<210>  7
<211>  43
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimicrobial peptide based on North American bullfrog, Rana 
       (Lithobates) catesbeiana

<400>  7

Met Thr Gln Ser Thr Gln Lys Trp Phe Lys Thr Lys Tyr Trp Arg Val 
1               5                   10                  15      


Arg Asn Arg Pro Ala Met Ser Pro Asp Leu Asn Pro Ile Glu His Leu 
            20                  25                  30          


Trp Arg Asp Leu Lys Lys Val Val Gly Lys Arg 
        35                  40              


<210>  8
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimicrobial peptide based on North American bullfrog, Rana 
       (Lithobates) catesbeiana

<400>  8

Asn Pro Ser Asn Leu Arg Ala Leu Glu Glu Leu Val Lys Glu Glu Cys 
1               5                   10                  15      


Ser Glu Ile Pro Val Glu Arg Cys Lys Lys Leu Ile Tyr Gly Tyr Arg 
            20                  25                  30          


Lys 
    


<210>  9
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimicrobial peptide based on North American bullfrog, Rana 
       (Lithobates) catesbeiana

<400>  9

Met Arg Lys Arg Met Thr Met Arg Arg Met Met Lys Lys Lys Lys Ser 
1               5                   10                  15      


Glu Lys Glu Arg Arg Glu Arg Gly Lys Arg 
            20                  25      


<210>  10
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimicrobial peptide based on North American bullfrog, Rana 
       (Lithobates) catesbeiana

<400>  10

Met Met Arg Val Met Arg Arg Lys Thr Lys Val Ile Trp Glu Lys Lys 
1               5                   10                  15      


Asp Phe Ile Gly Leu Tyr Ser Ile Asp 
            20                  25  


<210>  11
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimicrobial peptide based on North American bullfrog, Rana 
       (Lithobates) catesbeiana

<400>  11

Met Phe Phe Met Ser Ser Pro Arg Arg Asp Ala Asp Glu Val Lys Glu 
1               5                   10                  15      


Val Lys Arg 
            


<210>  12
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimicrobial peptide based on North American bullfrog, Rana 
       (Lithobates) catesbeiana

<400>  12

Gly Phe Leu Asp Ile Ile Lys Asn Leu Gly Lys Thr Phe Ala Gly His 
1               5                   10                  15      


Met Leu Asp Lys Ile Lys Cys Thr Ile Gly Thr Cys Pro Pro Ser Pro 
            20                  25                  30          


<210>  13
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimicrobial peptide based on North American bullfrog, Rana 
       (Lithobates) catesbeiana

<400>  13

Met Ile Thr Val Ser Ser Pro Arg Arg Asp Ala Asp Gly Asp Glu Gly 
1               5                   10                  15      


Glu Val Glu Glu Val Lys Arg 
            20              


<210>  14
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimicrobial peptide based on North American bullfrog, Rana 
       (Lithobates) catesbeiana

<400>  14

Gly Phe Leu Asp Ile Ile Lys Asp Thr Gly Lys Glu Phe Ala Val Lys 
1               5                   10                  15      


Ile Leu Asn Asn Leu Lys Cys Lys Leu Ala Gly Gly Cys Pro Pro 
            20                  25                  30      


<210>  15
<211>  71
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Putative AMP precursor based on Pseudacris regilla 
       Ranatuerin-2PRc

<400>  15

Met Phe Thr Met Lys Lys Ser Leu Leu Leu Phe Phe Phe Leu Gly Thr 
1               5                   10                  15      


Ile Ser Leu Ser Leu Cys Glu Glu Glu Arg Asp Ala Asp Asp Asp Gln 
            20                  25                  30          


Gly Glu Val Val Lys Lys Glu Val Lys Arg Ala Phe Phe Thr Thr Val 
        35                  40                  45              


Lys Asn Leu Val Thr Asn Val Ala Gly Thr Val Ile Asp Lys Met Lys 
    50                  55                  60                  


Cys Lys Leu Thr Gly Gln Cys 
65                  70      


<210>  16
<211>  71
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Putative AMP precursor based on R. catesbeiana HP2

<400>  16

Met Phe Thr Met Lys Lys Ser Leu Leu Leu Leu Phe Phe Leu Gly Thr 
1               5                   10                  15      


Ile Ser Leu Ser Leu Cys Glu Gln Glu Arg Asn Ala Asp Asp Asp Gln 
            20                  25                  30          


Gly Glu Val Ile Glu Gln Lys Val Lys Arg Ala Phe Leu Ser Thr Val 
        35                  40                  45              


Lys Asn Thr Leu Thr Asn Val Ala Gly Thr Met Ile Asp Thr Phe Lys 
    50                  55                  60                  


Cys Lys Ile Thr Gly Val Cys 
65                  70      


<210>  17
<211>  66
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Ranatuerin precursor sequences

<400>  17

Met Phe Thr Leu Lys Lys Ser Leu Leu Leu Leu Phe Phe Leu Gly Thr 
1               5                   10                  15      


Ile Thr Leu Ser Leu Cys Glu Gln Glu Arg Gly Ala Asp Glu Glu Glu 
            20                  25                  30          


Gly Asn Gly Glu Lys Glu Ile Lys Arg Ser Met Leu Ser Val Leu Lys 
        35                  40                  45              


Asn Leu Gly Lys Val Gly Leu Gly Phe Val Ala Cys Lys Ile Asn Lys 
    50                  55                  60                  


Gln Cys 
65      


<210>  18
<211>  61
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Ranatuerin precursor sequence

<400>  18

Met Ser Ser Phe Cys Glu Ile Thr Asn Val Ala Leu Thr Ile Ser Leu 
1               5                   10                  15      


Ser Ser Pro Arg Arg Gly Ala Asp Glu Glu Glu Gly Asn Gly Glu Lys 
            20                  25                  30          


Glu Ile Lys Arg Ser Met Leu Ser Val Leu Lys Asn Leu Gly Lys Val 
        35                  40                  45              


Gly Leu Gly Phe Val Ala Cys Lys Ile Asn Lys Gln Cys 
    50                  55                  60      


<210>  19
<211>  51
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Ranatuerin precursor sequence

<400>  19

Met Phe Phe Met Ser Ser Pro Arg Arg Asp Ala Asp Glu Val Lys Glu 
1               5                   10                  15      


Val Lys Arg Gly Phe Leu Asp Ile Ile Lys Asn Leu Gly Lys Thr Phe 
            20                  25                  30          


Ala Gly His Met Leu Asp Lys Ile Lys Cys Thr Ile Gly Thr Cys Pro 
        35                  40                  45              


Pro Ser Pro 
    50      


<210>  20
<211>  68
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Ranatuerin precursor sequence

<400>  20

Met Phe Thr Met Lys Lys Ser Leu Leu Leu Leu Phe Phe Leu Gly Thr 
1               5                   10                  15      


Ile Ser Leu Ser Leu Cys Glu Pro Gln Arg Asp Ala Asp Glu Val Lys 
            20                  25                  30          


Glu Val Lys Arg Gly Phe Leu Asp Ile Ile Lys Asn Leu Gly Lys Thr 
        35                  40                  45              


Phe Ala Gly His Met Leu Asp Lys Ile Lys Cys Thr Ile Gly Thr Cys 
    50                  55                  60                  


Pro Pro Ser Pro 
65              


<210>  21
<211>  70
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Ranatuerin precursor sequence

<400>  21

Met Phe Thr Leu Lys Lys Ser Leu Leu Leu Leu Phe Phe Leu Gly Thr 
1               5                   10                  15      


Ile Asn Leu Ser Leu Cys Glu Glu Glu Arg Asp Ala Glu Glu Glu Arg 
            20                  25                  30          


Arg Asp Asn Pro Asp Glu Arg Asp Val Glu Val Glu Lys Arg Phe Leu 
        35                  40                  45              


Pro Phe Ile Ala Arg Leu Ala Ala Lys Val Phe Pro Ser Ile Ile Cys 
    50                  55                  60                  


Ser Val Thr Lys Lys Cys 
65                  70  


<210>  22
<211>  71
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Ranatuerin precursor sequence

<400>  22

Met Phe Thr Met Lys Lys Ser Leu Leu Leu Leu Phe Phe Leu Gly Thr 
1               5                   10                  15      


Ile Ser Leu Ser Leu Cys Glu Gln Glu Arg Asn Ala Asp Asp Asp Gln 
            20                  25                  30          


Gly Glu Val Ile Glu Gln Lys Val Lys Arg Ala Phe Leu Ser Thr Val 
        35                  40                  45              


Lys Asn Thr Leu Thr Asn Val Ala Gly Thr Met Ile Asp Thr Phe Lys 
    50                  55                  60                  


Cys Lys Ile Thr Gly Val Cys 
65                  70      


<210>  23
<211>  74
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Ranatuerin precursor sequence

<400>  23

Met Phe Thr Leu Lys Lys Ser Leu Leu Leu Leu Phe Phe Leu Gly Thr 
1               5                   10                  15      


Ile Thr Leu Ser Leu Cys Glu Gln Glu Arg Gly Ala Asp Glu Asp Asn 
            20                  25                  30          


Gly Gly Glu Met Thr Glu Glu Glu Val Lys Arg Gly Leu Phe Leu Asp 
        35                  40                  45              


Thr Leu Lys Gly Ala Ala Lys Asp Val Ala Gly Lys Leu Leu Glu Gly 
    50                  55                  60                  


Leu Lys Cys Lys Ile Thr Gly Cys Lys Pro 
65                  70                  


<210>  24
<211>  67
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Ranacyclin precursor sequence from R. catesbeiana

<400>  24

Met Phe Thr Met Lys Lys Ser Leu Leu Leu Leu Phe Phe Leu Gly Ile 
1               5                   10                  15      


Ile Ser Leu Ser Leu Cys Glu Gln Glu Arg Asp Ala Asn Asp Glu Glu 
            20                  25                  30          


Asp Gly Gly Glu Val Thr Lys Glu Val Val Lys Arg Ser Leu Arg Gly 
        35                  40                  45              


Cys Trp Thr Lys Ser Phe Pro Pro Gln Pro Cys Leu Gly Lys Arg Leu 
    50                  55                  60                  


Asn Met Asn 
65          


<210>  25
<211>  63
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Ranacyclin precursor sequence from R. catesbeiana

<400>  25

Met Phe Thr Leu Lys Lys Ser Leu Leu Leu Leu Phe Phe Phe Gly Ile 
1               5                   10                  15      


Ile Ser Leu Ser Phe Cys Glu Gln Glu Arg Asp Ala Asn Asp Glu Glu 
            20                  25                  30          


Asp Gly Gly Glu Val Thr Lys Glu Val Val Lys Arg Ser Leu Arg Gly 
        35                  40                  45              


Cys Trp Thr Lys Ser Tyr Pro Pro Gln Pro Cys Leu Gly Lys Arg 
    50                  55                  60              


<210>  26
<211>  50
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Ranacyclin precursor sequence from R. catesbeiana

<400>  26

Val Leu Leu Tyr Leu Ile Ile Thr Val Ser Phe Pro Arg Arg Asp Ala 
1               5                   10                  15      


Asn Asp Glu Asp Gly Gly Glu Val Thr Lys Glu Val Val Lys Arg Ser 
            20                  25                  30          


Leu Ser Gly Cys Trp Thr Lys Ser Phe Pro Arg Lys Pro Cys Leu Arg 
        35                  40                  45              


Asn Arg 
    50  


<210>  27
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Catesbeianin-1 precursor sequence from R. catesbeiana

<400>  27

Met Phe Thr Met Lys Lys Ser Glu Lys Glu Arg Arg Glu Arg Gly Lys 
1               5                   10                  15      


Arg Met Met Arg Val Met Arg Arg Lys Thr Lys Val Ile Trp Glu Lys 
            20                  25                  30          


Lys Asp Phe Ile Gly Leu Tyr Ser Ile Asp 
        35                  40          


<210>  28
<211>  51
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Catesbeianin-1 precursor sequence from R. catesbeiana

<400>  28

Met Arg Lys Arg Met Thr Met Arg Arg Met Met Lys Lys Lys Lys Ser 
1               5                   10                  15      


Glu Lys Glu Arg Arg Glu Arg Gly Lys Arg Met Met Arg Val Met Arg 
            20                  25                  30          


Arg Lys Thr Lys Val Ile Trp Glu Lys Lys Asp Phe Ile Gly Leu Tyr 
        35                  40                  45              


Ser Ile Asp 
    50      


<210>  29
<211>  71
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Palustrin-Ca precursor sequence from R. catesbeiana

<400>  29

Met Phe Thr Met Lys Lys Ser Leu Leu Leu Leu Phe Phe Leu Gly Thr 
1               5                   10                  15      


Ile Ser Leu Ser Leu Cys Glu Gln Glu Arg Asp Ala Asp Gly Asp Glu 
            20                  25                  30          


Gly Glu Val Glu Glu Val Lys Arg Gly Phe Leu Asp Ile Ile Lys Asp 
        35                  40                  45              


Thr Gly Lys Glu Phe Ala Val Lys Ile Leu Asn Asn Leu Lys Cys Lys 
    50                  55                  60                  


Leu Ala Gly Gly Cys Pro Pro 
65                  70      


<210>  30
<211>  54
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Palustrin-Ca precursor sequence from R. catesbeiana

<400>  30

Met Ile Thr Val Ser Ser Pro Arg Arg Asp Ala Asp Gly Asp Glu Gly 
1               5                   10                  15      


Glu Val Glu Glu Val Lys Arg Gly Phe Leu Asp Ile Ile Lys Asp Thr 
            20                  25                  30          


Gly Lys Glu Phe Ala Val Lys Ile Leu Asn Asn Leu Lys Cys Lys Leu 
        35                  40                  45              


Ala Gly Gly Cys Pro Pro 
    50                  


<210>  31
<211>  179
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Amolops loloensis Cathelicidin-AL sequence

<400>  31

Met Gly Leu Ser Ala Thr Leu Trp Phe Leu Met Gly Val Ala Ala Gly 
1               5                   10                  15      


Ser Met Ala Ser Pro Leu Leu Gln Trp Ser Glu Asp Asp Ile Ser Val 
            20                  25                  30          


Met Ala Leu Tyr Ser Thr Asp Tyr Tyr Asn Lys Val Ser Gly Glu Asp 
        35                  40                  45              


Val Leu Tyr Gly Leu Gln Glu Asn Asn Thr Glu Tyr Ile Thr Asp Glu 
    50                  55                  60                  


Lys Ser Arg Phe His Gln Leu Ser Phe Pro Ile Gln Lys Thr Val Cys 
65                  70                  75                  80  


Gln Lys Ser Asp Asn Ala Leu Thr Asp Asp Cys Ala Phe Lys Glu Gly 
                85                  90                  95      


Gly Val Val Lys Ser Cys Thr Ser Tyr Phe Phe Glu Glu Asp Asp Arg 
            100                 105                 110         


Asp Ile Ile Val Val Thr Cys Gln Ser Gln Asp Gly His Arg Glu His 
        115                 120                 125             


Ser Arg Val Arg Arg Ser Arg Arg Gly Arg Gly Gly Gly Arg Arg Gly 
    130                 135                 140                 


Gly Ser Gly Gly Arg Gly Gly Arg Gly Gly Gly Gly Arg Ser Gly Ala 
145                 150                 155                 160 


Gly Ser Ser Ile Ala Gly Val Gly Ser Arg Gly Gly Gly Gly Gly Arg 
                165                 170                 175     


His Tyr Ala 
            


<210>  32
<211>  181
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  R. catesbeiana Cathelicidin-AL sequence that aligns with an 
       Amolops loloensis Cathelicidin-AL sequence

<400>  32

Met Gly Leu Ser Ala Thr Phe Trp Phe Leu Met Gly Leu Ala Ala Ser 
1               5                   10                  15      


Ser Met Ala Ser Pro Leu Leu Gln Trp Ser Glu Asp Asp Ala Ala Val 
            20                  25                  30          


Met Ala Leu Tyr Ser Ala Asp His Tyr Asn Lys Val Ser Gly Glu Asp 
        35                  40                  45              


Val Leu Tyr Gly Leu Leu Glu Asn Asp Thr Glu Tyr Ile Thr Asp Glu 
    50                  55                  60                  


Lys Ser Arg Phe His Gln Leu Ser Phe Pro Ile Gln Glu Thr Val Cys 
65                  70                  75                  80  


Gln Lys Ser Asp Asn Asn Ala Pro Thr Asp Asp Cys Ala Phe Lys Glu 
                85                  90                  95      


Gly Gly Val Val Lys Ser Cys Thr Ser Tyr Phe Phe Glu Glu Asp Asp 
            100                 105                 110         


Arg Asp Ile Val Val Val Asn Cys Gln Ser Gln Asp Ser His Arg Glu 
        115                 120                 125             


His Ser Arg Val Arg Arg Ser Arg Ser Gly Arg Gly Gly Gly Gly Arg 
    130                 135                 140                 


Gly Gly Gly Gly Arg Gly Gly Ser Arg Gly Gly Ser Arg Ser Gly Ser 
145                 150                 155                 160 


Arg Ser Ser Ile Ala Gly Gly Gly Ser Arg Gly Gly Ser Arg Gly Gly 
                165                 170                 175     


Gly Thr Arg Tyr Ala 
            180     


<210>  33
<211>  81
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Nanorana parkeri predicted LEAP2 sequence

<400>  33

Met Ile Pro Gln Leu Arg Lys Trp Met Ala Ile Phe Val Met Cys Ile 
1               5                   10                  15      


Val Leu Ile His Gln Leu Glu Gly Ala Pro Met Asn Ser Asn Asp Gly 
            20                  25                  30          


Ser Lys Thr Ala Leu Arg Leu Arg Arg Met Thr Pro Phe Trp Arg Gly 
        35                  40                  45              


Leu Ser Leu Arg Pro Val Gly Ala Ser Cys Arg Asp Asp Thr Glu Cys 
    50                  55                  60                  


Leu Thr Arg Leu Cys Arg Asn Gln Arg Cys Ser Leu Lys Thr Phe Ala 
65                  70                  75                  80  


Asp 
    


<210>  34
<211>  81
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  R. catesbeiana LEAP2 sequence aligning with Nanorana parkeri 
       predicted LEAP2 sequence

<400>  34

Met Thr Pro Gln Leu Arg Lys Trp Thr Ala Ile Phe Val Ile Cys Ile 
1               5                   10                  15      


Val Leu Ile His Gln Leu Glu Gly Ala Pro Met Ser Asn Thr Ala Gly 
            20                  25                  30          


Ser Lys Thr Leu Leu Arg Leu Arg Arg Met Thr Pro Phe Trp Arg Gly 
        35                  40                  45              


Leu Ser Leu Arg Pro Val Gly Ala Ser Cys Arg Asp Asp Thr Glu Cys 
    50                  55                  60                  


Leu Thr Arg Leu Cys Arg Lys Glu Arg Cys Ser Leu Lys Thr Phe Ala 
65                  70                  75                  80  


Asp 
    


<210>  35
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P1_CCH, 'natural' antimicrobial peptide

<400>  35

Phe Tyr Phe Pro Val Ser Arg Lys Phe Gly Gly Lys 
1               5                   10          


<210>  36
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P1_CCH_F9R_Y2P, 'synthetic' AMP

<400>  36

Phe Pro Phe Pro Val Ser Arg Lys Arg Gly Gly Lys 
1               5                   10          


<210>  37
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P2_CCH, 'natural' AMP

<400>  37

Phe Phe Pro Arg Val Leu Pro Leu Ala Asn Lys Phe Leu Pro Thr Ile 
1               5                   10                  15      


Tyr Cys Ala Leu Pro Lys Ser Val Gly Asn 
            20                  25      


<210>  38
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P2_CCH_T15K_P7R, 'synthetic' AMP

<400>  38

Phe Phe Pro Arg Val Leu Arg Leu Ala Asn Lys Phe Leu Pro Lys Ile 
1               5                   10                  15      


Tyr Cys Ala Leu Pro Lys Ser Val Gly Asn 
            20                  25      


<210>  39
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P3_CCH, 'natural' AMP

<400>  39

Gly Leu Leu Asp Ile Ile Lys Asp Thr Gly Lys Thr Thr Gly Ile Leu 
1               5                   10                  15      


Met Asp Thr Leu Lys Cys Gln Met Thr Gly Arg Cys Pro Pro Ser Ser 
            20                  25                  30          


<210>  40
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P3_CCH_D8K_Q23C, 'synthetic' AMP

<400>  40

Gly Leu Leu Asp Ile Ile Lys Lys Thr Gly Lys Thr Thr Gly Ile Leu 
1               5                   10                  15      


Met Asp Thr Leu Lys Cys Cys Met Thr Gly Arg Cys Pro Pro Ser Ser 
            20                  25                  30          


<210>  41
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P4_CCH, 'natural' AMP

<400>  41

Gly Leu Leu Asp Ile Ile Lys Thr Thr Gly Lys Asp Phe Ala Val Lys 
1               5                   10                  15      


Ile Leu Asp Asn Leu Lys Cys Lys Leu Ala Gly Gly Cys Pro Pro 
            20                  25                  30      


<210>  42
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P4_CCH_P31K, 'synthetic' AMP

<400>  42

Gly Leu Leu Asp Ile Ile Lys Thr Thr Gly Lys Asp Phe Ala Val Lys 
1               5                   10                  15      


Ile Leu Asp Asn Leu Lys Cys Lys Leu Ala Gly Gly Cys Pro Lys 
            20                  25                  30      


<210>  43
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P5_CCH, 'natural' AMP

<400>  43

Phe Phe Pro Ile Ile Ala Arg Leu Ala Ala Lys Val Ile Pro Ser Leu 
1               5                   10                  15      


Val Cys Ala Val Thr Lys Lys Cys 
            20                  


<210>  44
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P5_CCH_A19K, 'synthetic' AMP

<400>  44

Phe Phe Pro Ile Ile Ala Arg Leu Ala Ala Lys Val Ile Pro Ser Leu 
1               5                   10                  15      


Val Cys Lys Val Thr Lys Lys Cys 
            20                  


<210>  45
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P6_CCH, 'natural' AMP

<400>  45

Gly Leu Trp Glu Thr Ile Lys Thr Thr Gly Lys Ser Ile Ala Leu Asn 
1               5                   10                  15      


Leu Leu Asp Lys Ile Lys Cys Lys Ile Ala Gly Gly Cys Pro Pro 
            20                  25                  30      


<210>  46
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P6_CCH_S12K, 'synthetic' AMP

<400>  46

Gly Leu Trp Glu Thr Ile Lys Thr Thr Gly Lys Lys Ile Ala Leu Asn 
1               5                   10                  15      


Leu Leu Asp Lys Ile Lys Cys Lys Ile Ala Gly Gly Cys Pro Pro 
            20                  25                  30      


<210>  47
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P7_CCH, 'natural' AMP

<400>  47

Ala Thr Ala Trp Arg Ile Pro Pro Pro Gly Met Gln Pro Ile Ile Pro 
1               5                   10                  15      


Ile Arg Ile Arg Pro Leu Cys Gly Lys Gln 
            20                  25      


<210>  48
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P7_CCH_P9R_R5M, 'synthetic' AMP

<400>  48

Ala Thr Ala Trp Met Ile Pro Pro Arg Gly Met Gln Pro Ile Ile Pro 
1               5                   10                  15      


Ile Arg Ile Arg Pro Leu Cys Gly Lys Gln 
            20                  25      


<210>  49
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P8_CCH, 'natural' AMP

<400>  49

Phe Pro Ala Ile Ile Cys Lys Val Ser Lys Asn Cys 
1               5                   10          


<210>  50
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P8_CCH_N11K, 'synthetic' AMP

<400>  50

Phe Pro Ala Ile Ile Cys Lys Val Ser Lys Lys Cys 
1               5                   10          


<210>  51
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P9_CCH_2, 'synthetic' AMP

<400>  51

Phe Leu Thr Lys Pro Gly Met Thr Phe Gly Lys Leu Leu Gly Lys 
1               5                   10                  15  


<210>  52
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P10_CCH, 'natural' AMP

<400>  52

Ser Asn Arg Asp Phe Phe Lys Val Asn Ile Phe Arg Leu Cys Gly 
1               5                   10                  15  


<210>  53
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P10_CCH_2, 'synthetic' AMP

<400>  53

Ser Asn Arg Lys Phe Phe Lys Val Arg Ile Phe Arg Leu Cys Gly 
1               5                   10                  15  


<210>  54
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P11_CCH, 'natural' AMP

<400>  54

Ala Leu Val Ala Lys Ile Gln Lys Phe Pro Val Phe Asn Thr Leu Lys 
1               5                   10                  15      


Leu Cys Lys Leu Glu Leu Glu Ile Ile 
            20                  25  


<210>  55
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P11_CCH_E21K_E23R, 'synthetic' AMP

<400>  55

Ala Leu Val Ala Lys Ile Gln Lys Phe Pro Val Phe Asn Thr Leu Lys 
1               5                   10                  15      


Leu Cys Lys Leu Lys Leu Arg Ile Ile 
            20                  25  


<210>  56
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P12_CCH, 'natural' AMP

<400>  56

Ile Ala Gly Gln Val Ala Ala Ala Lys Gln Lys His Ile 
1               5                   10              


<210>  57
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P12_CCH2, 'synthetic' AMP

<400>  57

Ile Ala Gly Gln Lys Ala Arg Ala Lys Gln Lys His Ile 
1               5                   10              


<210>  58
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P13_CCH, 'natural' AMP

<400>  58

Ile Gln Arg Leu Pro Val Ile Asn Met Leu Lys Leu Trp Lys Leu Glu 
1               5                   10                  15      


Leu Glu Ile Ile 
            20  


<210>  59
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P13_CCH_N8K_E18K, 'synthetic' AMP

<400>  59

Ile Gln Arg Leu Pro Val Ile Lys Met Leu Lys Leu Trp Lys Leu Glu 
1               5                   10                  15      


Leu Lys Ile Ile 
            20  


<210>  60
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P14_CCH, 'natural' AMP

<400>  60

Ile Gln Arg Leu Pro Val Ile Val Ile Leu Pro Ser Leu Tyr Cys Val 
1               5                   10                  15      


Ile Cys Arg Thr Cys 
            20      


<210>  61
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P14_CCH_2, 'synthetic' AMP

<400>  61

Ile Gln Arg Leu Pro Val Ile Val Ile Leu Pro Ser Leu Tyr Cys Val 
1               5                   10                  15      


Ile Cys Arg Lys Lys 
            20      


<210>  62
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P15_CCH, 'natural' AMP

<400>  62

Leu Arg Cys Pro Thr Pro His Tyr Asn Phe Glu Asn Gly Ile Gly Asn 
1               5                   10                  15      


His Leu Met Trp Asn Ile Ile Trp Leu Asn Ala Gln Gln Met Ser Tyr 
            20                  25                  30          


Lys Asn Lys 
        35  


<210>  63
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P15_CCH_2, 'synthetic' AMP

<400>  63

Leu Arg Cys Pro Thr Pro His Tyr Arg Phe Glu Asn Gly Ile Gly Asn 
1               5                   10                  15      


His Leu Met Trp Asn Ile Ile Trp Leu Asn Ala Gln Gln Met Ser Tyr 
            20                  25                  30          


Cys Asn Lys 
        35  


<210>  64
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P16_CCH, 'natural' AMP

<400>  64

Ser Asn Arg Asp Phe Phe Met Val Asn Ile Phe Gly Leu Cys Gly Pro 
1               5                   10                  15      


Phe Gly Ile Met Glu Arg Lys Arg Arg 
            20                  25  


<210>  65
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P16_CCH_2, 'synthetic' AMP

<400>  65

Ser Asn Arg Lys Phe Phe Met Val Asn Ile Phe Gly Leu Cys Gly Pro 
1               5                   10                  15      


Phe Gly Ile Met Lys Arg Lys Arg Arg 
            20                  25  


<210>  66
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  P1 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(9)
<223>  Xaa is any amino acid

<400>  66

Xaa Xaa Xaa Pro Xaa Xaa Xaa Xaa Xaa Gly Gly Lys 
1               5                   10          


<210>  67
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P1 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (5)..(9)
<223>  Xaa is any amino acid

<400>  67

Phe Tyr Phe Pro Xaa Xaa Xaa Xaa Xaa Gly Gly Lys 
1               5                   10          


<210>  68
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P1 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(12)
<223>  Xaa is any amino acid

<400>  68

Xaa Tyr Phe Xaa Xaa Ser Arg Lys Xaa Xaa Xaa Xaa 
1               5                   10          


<210>  69
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P1 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (2)..(12)
<223>  Xaa is any amino acid

<400>  69

Phe Xaa Phe Xaa Val Ser Arg Lys Xaa Xaa Xaa Xaa 
1               5                   10          


<210>  70
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P1 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  Xaa is any amino acid

<400>  70

Xaa Tyr Phe Xaa Xaa Xaa Xaa Lys Phe Xaa Xaa Lys 
1               5                   10          


<210>  71
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P1 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(8)
<223>  Xaa is any amino acid

<400>  71

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Phe Gly Gly Lys 
1               5                   10          


<210>  72
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P1 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (2)..(12)
<223>  Xaa is any amino acid

<400>  72

Phe Tyr Xaa Pro Val Xaa Arg Xaa Phe Xaa Xaa Xaa 
1               5                   10          


<210>  73
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P2 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (5)..(22)
<223>  Xaa is any amino acid

<400>  73

Phe Phe Pro Arg Xaa Xaa Xaa Xaa Xaa Xaa Xaa Phe Leu Pro Thr Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Xaa Ser Val Gly Asn 
            20                  25      


<210>  74
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P2 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(26)
<223>  Xaa is any amino acid

<400>  74

Xaa Xaa Xaa Xaa Val Leu Pro Leu Ala Asn Lys Xaa Xaa Xaa Xaa Ile 
1               5                   10                  15      


Tyr Cys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
            20                  25      


<210>  75
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P2 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (4)..(23)
<223>  Xaa is any amino acid

<400>  75

Phe Phe Pro Xaa Xaa Leu Pro Leu Ala Asn Xaa Xaa Leu Pro Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Leu Pro Xaa Xaa Val Gly Asn 
            20                  25      


<210>  76
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P2 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(26)
<223>  Xaa is any amino acid

<400>  76

Xaa Xaa Pro Arg Val Leu Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Pro Lys Ser Xaa Xaa Xaa 
            20                  25      


<210>  77
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P2 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (2)..(26)
<223>  Xaa is any amino acid

<400>  77

Phe Xaa Xaa Xaa Xaa Xaa Xaa Leu Ala Asn Lys Xaa Xaa Xaa Thr Ile 
1               5                   10                  15      


Tyr Cys Xaa Xaa Xaa Xaa Ser Val Xaa Xaa 
            20                  25      


<210>  78
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P2 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (3)..(25)
<223>  Xaa is any amino acid

<400>  78

Phe Phe Xaa Xaa Val Leu Pro Xaa Xaa Xaa Xaa Xaa Leu Xaa Thr Xaa 
1               5                   10                  15      


Tyr Cys Ala Leu Pro Lys Xaa Val Xaa Asn 
            20                  25      


<210>  79
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P2 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(26)
<223>  Xaa is any amino acid

<400>  79

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Leu Ala Asn Xaa Phe Xaa Pro Xaa Ile 
1               5                   10                  15      


Xaa Xaa Ala Leu Pro Lys Xaa Xaa Gly Xaa 
            20                  25      


<210>  80
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P3 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (4)..(27)
<223>  Xaa is any amino acid

<400>  80

Gly Leu Leu Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Cys Pro Pro Ser Ser 
            20                  25                  30          


<210>  81
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P3 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(31)
<223>  Xaa is any amino acid

<400>  81

Xaa Xaa Xaa Xaa Xaa Xaa Lys Xaa Xaa Xaa Lys Xaa Xaa Gly Xaa Leu 
1               5                   10                  15      


Met Xaa Xaa Xaa Xaa Xaa Xaa Met Xaa Gly Xaa Xaa Pro Pro Xaa Ser 
            20                  25                  30          


<210>  82
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P3 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (4)..(32)
<223>  Xaa is any amino acid

<400>  82

Gly Leu Leu Xaa Ile Ile Xaa Xaa Xaa Gly Xaa Thr Thr Gly Ile Leu 
1               5                   10                  15      


Met Xaa Xaa Leu Xaa Xaa Xaa Met Xaa Gly Xaa Xaa Pro Pro Xaa Xaa 
            20                  25                  30          


<210>  83
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P3 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(30)
<223>  Xaa is any amino acid

<400>  83

Xaa Leu Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Lys Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Thr Leu Lys Cys Gln Met Thr Xaa Xaa Cys Xaa Xaa Ser Ser 
            20                  25                  30          


<210>  84
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P3 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (4)..(32)
<223>  Xaa is any amino acid

<400>  84

Gly Leu Leu Xaa Ile Ile Lys Xaa Thr Gly Lys Thr Thr Gly Ile Leu 
1               5                   10                  15      


Met Xaa Xaa Leu Lys Xaa Xaa Xaa Xaa Gly Xaa Xaa Xaa Xaa Xaa Xaa 
            20                  25                  30          


<210>  85
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P3 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (2)..(28)
<223>  Xaa is any amino acid

<400>  85

Gly Xaa Leu Xaa Ile Ile Lys Xaa Thr Gly Xaa Xaa Thr Xaa Ile Xaa 
1               5                   10                  15      


Met Xaa Thr Leu Lys Cys Gln Xaa Thr Gly Arg Xaa Pro Pro Ser Ser 
            20                  25                  30          


<210>  86
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P3 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (4)..(32)
<223>  Xaa is any amino acid

<400>  86

Gly Leu Leu Xaa Xaa Xaa Lys Xaa Thr Gly Lys Xaa Thr Xaa Ile Xaa 
1               5                   10                  15      


Xaa Xaa Thr Leu Lys Xaa Gln Xaa Thr Gly Arg Xaa Xaa Xaa Xaa Xaa 
            20                  25                  30          


<210>  87
<211>  32
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P3 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(32)
<223>  Xaa is any amino acid

<400>  87

Xaa Xaa Xaa Xaa Ile Ile Xaa Xaa Thr Xaa Xaa Thr Xaa Gly Xaa Leu 
1               5                   10                  15      


Xaa Xaa Thr Xaa Xaa Cys Gln Xaa Thr Xaa Arg Xaa Xaa Xaa Xaa Xaa 
            20                  25                  30          


<210>  88
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P4 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (4)..(31)
<223>  Xaa is any amino acid

<400>  88

Gly Leu Leu Xaa Ile Ile Xaa Xaa Xaa Gly Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Ile Leu Xaa Xaa Leu Xaa Xaa Xaa Leu Ala Gly Gly Xaa Xaa Xaa 
            20                  25                  30      


<210>  89
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P4 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (4)..(29)
<223>  Xaa is any amino acid

<400>  89

Gly Leu Leu Xaa Xaa Xaa Lys Thr Thr Gly Lys Xaa Phe Ala Val Lys 
1               5                   10                  15      


Ile Leu Xaa Asn Leu Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Pro Pro 
            20                  25                  30      


<210>  90
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P4 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(31)
<223>  Xaa is any amino acid

<400>  90

Xaa Xaa Xaa Xaa Ile Ile Lys Thr Xaa Xaa Xaa Xaa Phe Ala Val Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Lys Cys Lys Leu Ala Gly Gly Xaa Xaa Xaa 
            20                  25                  30      


<210>  91
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P4 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(28)
<223>  Xaa is any amino acid

<400>  91

Xaa Xaa Xaa Xaa Ile Ile Xaa Xaa Xaa Xaa Lys Xaa Xaa Xaa Xaa Lys 
1               5                   10                  15      


Xaa Xaa Xaa Asn Leu Lys Cys Lys Xaa Xaa Xaa Xaa Cys Pro Pro 
            20                  25                  30      


<210>  92
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P4 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (4)..(31)
<223>  Xaa is any amino acid

<400>  92

Gly Leu Leu Xaa Xaa Xaa Lys Thr Thr Gly Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Leu Xaa Asn Leu Lys Cys Xaa Xaa Ala Xaa Xaa Cys Xaa Xaa 
            20                  25                  30      


<210>  93
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P4 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (4)..(29)
<223>  Xaa is any amino acid

<400>  93

Gly Leu Leu Xaa Xaa Xaa Lys Xaa Xaa Xaa Xaa Xaa Phe Ala Val Xaa 
1               5                   10                  15      


Xaa Leu Xaa Xaa Leu Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Pro Pro 
            20                  25                  30      


<210>  94
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P5 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(21)
<223>  Xaa is any amino acid

<400>  94

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Leu Ala Ala Lys Xaa Xaa Xaa Ser Leu 
1               5                   10                  15      


Val Xaa Xaa Xaa Xaa Lys Lys Cys 
            20                  


<210>  95
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P5 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(24)
<223>  Xaa is any amino acid

<400>  95

Xaa Phe Pro Ile Ile Ala Xaa Leu Ala Ala Xaa Val Ile Pro Xaa Leu 
1               5                   10                  15      


Val Xaa Ala Val Thr Xaa Xaa Xaa 
            20                  


<210>  96
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P5 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (4)..(24)
<223>  Xaa is any amino acid

<400>  96

Phe Phe Pro Xaa Xaa Ala Xaa Xaa Xaa Xaa Lys Xaa Xaa Pro Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
            20                  


<210>  97
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P5 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(24)
<223>  Xaa is any amino acid

<400>  97

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Leu Ala Ala Xaa Val Ile Pro Xaa Leu 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Thr Xaa Xaa Xaa 
            20                  


<210>  98
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P5 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (7)..(16)
<223>  Xaa is any amino acid

<400>  98

Phe Phe Pro Ile Ile Ala Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Val Cys Ala Val Thr Lys Lys Cys 
            20                  


<210>  99
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P5 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(19)
<223>  Xaa is any amino acid

<400>  99

Xaa Xaa Xaa Ile Ile Xaa Arg Xaa Xaa Xaa Lys Val Ile Xaa Ser Xaa 
1               5                   10                  15      


Val Cys Xaa Val Thr Lys Lys Cys 
            20                  


<210>  100
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P5 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (11)..(24)
<223>  Xaa is any amino acid

<400>  100

Phe Phe Pro Ile Ile Ala Arg Leu Ala Ala Xaa Val Ile Xaa Ser Leu 
1               5                   10                  15      


Xaa Cys Ala Val Xaa Xaa Xaa Xaa 
            20                  


<210>  101
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P6 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (8)..(26)
<223>  Xaa is any amino acid

<400>  101

Gly Leu Trp Glu Thr Ile Lys Xaa Xaa Xaa Lys Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Lys Xaa Xaa Xaa Xaa Xaa Xaa Gly Gly Cys Pro Pro 
            20                  25                  30      


<210>  102
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P6 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(31)
<223>  Xaa is any amino acid

<400>  102

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Thr Thr Gly Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Lys Cys Lys Xaa Xaa Xaa Xaa Cys Xaa Xaa 
            20                  25                  30      


<210>  103
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P6 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(29)
<223>  Xaa is any amino acid

<400>  103

Xaa Xaa Xaa Xaa Thr Ile Xaa Xaa Xaa Gly Xaa Xaa Ile Ala Leu Xaa 
1               5                   10                  15      


Leu Leu Xaa Xaa Ile Xaa Xaa Xaa Ile Ala Xaa Xaa Xaa Pro Pro 
            20                  25                  30      


<210>  104
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P6 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (6)..(29)
<223>  Xaa is any amino acid

<400>  104

Gly Leu Trp Glu Thr Xaa Lys Thr Thr Xaa Xaa Ser Xaa Xaa Leu Asn 
1               5                   10                  15      


Leu Leu Asp Lys Ile Xaa Xaa Lys Ile Ala Xaa Xaa Xaa Pro Pro 
            20                  25                  30      


<210>  105
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P6 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(31)
<223>  Xaa is any amino acid

<400>  105

Xaa Xaa Xaa Xaa Xaa Ile Lys Xaa Xaa Gly Lys Ser Ile Ala Leu Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Lys Xaa Lys Xaa Lys Xaa Xaa Gly Gly Xaa Xaa Xaa 
            20                  25                  30      


<210>  106
<211>  31
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P6 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(31)
<223>  Xaa is any amino acid

<400>  106

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Lys Ser Ile Ala Xaa Asn 
1               5                   10                  15      


Leu Leu Xaa Xaa Ile Xaa Cys Xaa Ile Ala Gly Gly Xaa Xaa Xaa 
            20                  25                  30      


<210>  107
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P7 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (5)..(26)
<223>  Xaa is any amino acid

<400>  107

Ala Thr Ala Trp Xaa Ile Xaa Xaa Xaa Gly Met Xaa Xaa Ile Ile Xaa 
1               5                   10                  15      


Ile Xaa Ile Xaa Xaa Leu Xaa Gly Xaa Xaa 
            20                  25      


<210>  108
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P7 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(22)
<223>  Xaa is any amino acid

<400>  108

Xaa Xaa Xaa Trp Xaa Ile Xaa Xaa Xaa Gly Met Gln Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Xaa Cys Gly Lys Gln 
            20                  25      


<210>  109
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P7 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(26)
<223>  Xaa is any amino acid

<400>  109

Xaa Xaa Xaa Xaa Xaa Xaa Pro Pro Pro Xaa Xaa Gln Pro Xaa Xaa Pro 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Pro Xaa Xaa Xaa Xaa Xaa 
            20                  25      


<210>  110
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P7 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (4)..(24)
<223>  Xaa is any amino acid

<400>  110

Ala Thr Ala Xaa Xaa Xaa Pro Pro Pro Xaa Xaa Xaa Pro Xaa Xaa Pro 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Pro Xaa Cys Xaa Lys Gln 
            20                  25      


<210>  111
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P7 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(26)
<223>  Xaa is any amino acid

<400>  111

Xaa Xaa Xaa Trp Xaa Ile Xaa Xaa Xaa Gly Met Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Ile Xaa Ile Xaa Xaa Leu Xaa Gly Xaa Xaa 
            20                  25      


<210>  112
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P7 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(26)
<223>  Xaa is any amino acid

<400>  112

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Pro Xaa Xaa Pro 
1               5                   10                  15      


Xaa Xaa Ile Xaa Xaa Leu Xaa Gly Xaa Xaa 
            20                  25      


<210>  113
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P7 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (4)..(24)
<223>  Xaa is any amino acid

<400>  113

Ala Thr Ala Xaa Arg Xaa Xaa Xaa Xaa Xaa Xaa Gln Xaa Ile Ile Xaa 
1               5                   10                  15      


Ile Arg Ile Arg Xaa Leu Cys Xaa Lys Gln 
            20                  25      


<210>  114
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P8 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (6)..(12)
<223>  Xaa is any amino acid

<400>  114

Phe Pro Ala Ile Ile Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10          


<210>  115
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P8 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (2)..(11)
<223>  Xaa is any amino acid

<400>  115

Phe Xaa Xaa Xaa Xaa Cys Xaa Xaa Xaa Lys Xaa Cys 
1               5                   10          


<210>  116
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P8 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(12)
<223>  Xaa is any amino acid

<400>  116

Xaa Xaa Ala Ile Ile Xaa Xaa Val Ser Lys Xaa Xaa 
1               5                   10          


<210>  117
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P8 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(12)
<223>  Xaa is any amino acid

<400>  117

Xaa Pro Ala Xaa Xaa Cys Lys Xaa Xaa Xaa Xaa Xaa 
1               5                   10          


<210>  118
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P8 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (3)..(7)
<223>  Xaa is any amino acid

<400>  118

Phe Pro Xaa Xaa Xaa Xaa Xaa Val Ser Lys Asn Cys 
1               5                   10          


<210>  119
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P8 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(12)
<223>  Xaa is any amino acid

<400>  119

Xaa Xaa Xaa Ile Ile Cys Lys Val Ser Xaa Asn Xaa 
1               5                   10          


<210>  120
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P9 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (5)..(15)
<223>  Xaa is any amino acid

<400>  120

Phe Leu Thr Phe Xaa Gly Xaa Xaa Phe Gly Xaa Xaa Xaa Gly Xaa 
1               5                   10                  15  


<210>  121
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P9 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Xaa is any amino acid

<400>  121

Xaa Xaa Xaa Xaa Pro Gly Met Xaa Phe Xaa Xaa Leu Leu Xaa Xaa 
1               5                   10                  15  


<210>  122
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P9 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(14)
<223>  Xaa is any amino acid

<400>  122

Xaa Xaa Xaa Xaa Pro Gly Met Xaa Xaa Xaa Lys Xaa Xaa Xaa Lys 
1               5                   10                  15  


<210>  123
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P9 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (5)..(15)
<223>  Xaa is any amino acid

<400>  123

Phe Leu Thr Phe Xaa Xaa Xaa Xaa Xaa Xaa Xaa Leu Leu Gly Xaa 
1               5                   10                  15  


<210>  124
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P9 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (2)..(14)
<223>  Xaa is any amino acid

<400>  124

Phe Xaa Xaa Phe Xaa Xaa Xaa Thr Phe Gly Lys Xaa Xaa Xaa Lys 
1               5                   10                  15  


<210>  125
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P9 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(7)
<223>  Xaa is any amino acid

<400>  125

Xaa Leu Thr Xaa Xaa Xaa Xaa Thr Phe Gly Lys Leu Leu Gly Lys 
1               5                   10                  15  


<210>  126
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P10 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Xaa is any amino acid

<400>  126

Xaa Xaa Xaa Xaa Phe Phe Xaa Val Asn Ile Phe Xaa Leu Xaa Xaa 
1               5                   10                  15  


<210>  127
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P10 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (3)..(15)
<223>  Xaa is any amino acid

<400>  127

Ser Asn Xaa Xaa Xaa Xaa Xaa Val Xaa Xaa Xaa Arg Xaa Xaa Xaa 
1               5                   10                  15  


<210>  128
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P10 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(12)
<223>  Xaa is any amino acid

<400>  128

Xaa Xaa Xaa Xaa Phe Phe Xaa Xaa Xaa Ile Phe Xaa Leu Cys Gly 
1               5                   10                  15  


<210>  129
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P10 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (3)..(12)
<223>  Xaa is any amino acid

<400>  129

Ser Asn Xaa Xaa Xaa Xaa Lys Xaa Xaa Xaa Xaa Xaa Leu Cys Gly 
1               5                   10                  15  


<210>  130
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P10 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  Xaa is any amino acid

<400>  130

Xaa Xaa Arg Xaa Xaa Xaa Lys Val Asn Ile Phe Xaa Xaa Cys Xaa 
1               5                   10                  15  


<210>  131
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P10 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (2)..(14)
<223>  Xaa is any amino acid

<400>  131

Ser Xaa Xaa Xaa Phe Phe Xaa Val Xaa Ile Xaa Xaa Xaa Xaa Gly 
1               5                   10                  15  


<210>  132
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P10 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (2)..(15)
<223>  Xaa is any amino acid

<400>  132

Ser Xaa Arg Asp Phe Phe Lys Xaa Asn Xaa Xaa Arg Xaa Cys Xaa 
1               5                   10                  15  


<210>  133
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P11 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(25)
<223>  Xaa is any amino acid

<400>  133

Xaa Xaa Xaa Xaa Xaa Ile Gln Lys Xaa Xaa Xaa Xaa Asn Thr Leu Lys 
1               5                   10                  15      


Xaa Xaa Lys Xaa Xaa Leu Xaa Xaa Xaa 
            20                  25  


<210>  134
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P11 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (6)..(25)
<223>  Xaa is any amino acid

<400>  134

Ala Leu Val Ala Lys Xaa Xaa Xaa Phe Pro Val Phe Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Leu Cys Xaa Leu Xaa Xaa Xaa Xaa Xaa 
            20                  25  


<210>  135
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P11 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (9)..(23)
<223>  Xaa is any amino acid

<400>  135

Ala Leu Val Ala Lys Ile Gln Lys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Lys Leu Xaa Xaa Xaa Ile Ile 
            20                  25  


<210>  136
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P11 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(25)
<223>  Xaa is any amino acid

<400>  136

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Lys Xaa Pro Xaa Xaa Asn Thr Leu Lys 
1               5                   10                  15      


Xaa Cys Lys Xaa Glu Xaa Glu Xaa Xaa 
            20                  25  


<210>  137
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P11 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(25)
<223>  Xaa is any amino acid

<400>  137

Xaa Xaa Xaa Xaa Xaa Xaa Gln Xaa Phe Xaa Val Phe Xaa Thr Leu Lys 
1               5                   10                  15      


Leu Xaa Lys Leu Xaa Leu Xaa Xaa Xaa 
            20                  25  


<210>  138
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P11 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(23)
<223>  Xaa is any amino acid

<400>  138

Xaa Leu Val Ala Lys Ile Xaa Xaa Xaa Pro Val Xaa Asn Xaa Xaa Xaa 
1               5                   10                  15      


Leu Xaa Xaa Xaa Xaa Leu Xaa Ile Ile 
            20                  25  


<210>  139
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P11 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (2)..(22)
<223>  Xaa is any amino acid

<400>  139

Ala Xaa Xaa Ala Xaa Ile Xaa Xaa Phe Xaa Xaa Phe Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Cys Xaa Xaa Glu Xaa Glu Ile Ile 
            20                  25  


<210>  140
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P12 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(13)
<223>  Xaa is any amino acid

<400>  140

Xaa Xaa Gly Gln Val Xaa Xaa Xaa Lys Xaa Lys Xaa Xaa 
1               5                   10              


<210>  141
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P12 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (3)..(13)
<223>  Xaa is any amino acid

<400>  141

Ile Ala Xaa Xaa Xaa Ala Ala Ala Xaa Xaa Xaa Xaa Xaa 
1               5                   10              


<210>  142
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P12 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(10)
<223>  Xaa is any amino acid

<400>  142

Xaa Xaa Gly Xaa Xaa Xaa Xaa Xaa Lys Xaa Lys His Ile 
1               5                   10              


<210>  143
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P12 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (2)..(8)
<223>  Xaa is any amino acid

<400>  143

Ile Xaa Xaa Gln Val Xaa Xaa Xaa Lys Gln Lys His Ile 
1               5                   10              


<210>  144
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P12 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  Xaa is any amino acid

<400>  144

Xaa Xaa Xaa Gln Val Xaa Xaa Xaa Xaa Gln Xaa His Ile 
1               5                   10              


<210>  145
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P13 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(20)
<223>  Xaa is any amino acid

<400>  145

Xaa Xaa Arg Xaa Pro Xaa Xaa Xaa Xaa Xaa Lys Leu Trp Lys Xaa Xaa 
1               5                   10                  15      


Leu Xaa Xaa Xaa 
            20  


<210>  146
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P13 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (3)..(18)
<223>  Xaa is any amino acid

<400>  146

Ile Gln Xaa Xaa Xaa Val Xaa Xaa Xaa Leu Xaa Xaa Xaa Xaa Leu Xaa 
1               5                   10                  15      


Xaa Xaa Ile Ile 
            20  


<210>  147
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P13 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(20)
<223>  Xaa is any amino acid

<400>  147

Xaa Xaa Xaa Leu Xaa Xaa Xaa Asn Met Xaa Xaa Xaa Trp Lys Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa 
            20  


<210>  148
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P13 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(20)
<223>  Xaa is any amino acid

<400>  148

Xaa Xaa Xaa Leu Pro Xaa Ile Asn Met Xaa Lys Leu Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Leu Xaa Xaa Xaa 
            20  


<210>  149
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P14 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (5)..(17)
<223>  Xaa is any amino acid

<400>  149

Ile Gln Arg Leu Xaa Xaa Xaa Xaa Xaa Xaa Xaa Ser Leu Tyr Xaa Xaa 
1               5                   10                  15      


Xaa Cys Arg Thr Cys 
            20      


<210>  150
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P14 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(21)
<223>  Xaa is any amino acid

<400>  150

Xaa Xaa Xaa Leu Pro Val Xaa Val Xaa Leu Pro Ser Leu Tyr Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa 
            20      


<210>  151
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P14 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (4)..(21)
<223>  Xaa is any amino acid

<400>  151

Ile Gln Arg Xaa Xaa Xaa Ile Val Ile Xaa Xaa Xaa Xaa Xaa Cys Val 
1               5                   10                  15      


Ile Xaa Xaa Xaa Xaa 
            20      


<210>  152
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P14 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(17)
<223>  Xaa is any amino acid

<400>  152

Xaa Xaa Xaa Xaa Pro Val Xaa Xaa Xaa Xaa Pro Ser Leu Tyr Xaa Xaa 
1               5                   10                  15      


Xaa Cys Arg Thr Cys 
            20      


<210>  153
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P14 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (5)..(20)
<223>  Xaa is any amino acid

<400>  153

Ile Gln Arg Leu Xaa Val Ile Xaa Ile Leu Xaa Xaa Xaa Xaa Cys Xaa 
1               5                   10                  15      


Xaa Cys Xaa Xaa Cys 
            20      


<210>  154
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P14 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(21)
<223>  Xaa is any amino acid

<400>  154

Xaa Xaa Xaa Leu Pro Xaa Xaa Xaa Xaa Xaa Pro Xaa Xaa Xaa Xaa Val 
1               5                   10                  15      


Ile Xaa Xaa Thr Xaa 
            20      


<210>  155
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P14 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(11)
<223>  Xaa is any amino acid

<400>  155

Xaa Xaa Xaa Leu Xaa Val Ile Val Ile Leu Xaa Ser Leu Tyr Cys Val 
1               5                   10                  15      


Ile Cys Arg Thr Cys 
            20      


<210>  156
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P15 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (2)..(35)
<223>  Xaa is any amino acid

<400>  156

Leu Xaa Xaa Pro Xaa Pro Xaa Tyr Xaa Phe Xaa Xaa Gly Ile Gly Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Trp Xaa Xaa Xaa Trp Leu Asn Ala Gln Gln Met Xaa Xaa 
            20                  25                  30          


Xaa Xaa Xaa 
        35  


<210>  157
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P15 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(35)
<223>  Xaa is any amino acid

<400>  157

Xaa Xaa Cys Pro Thr Pro Xaa Xaa Xaa Phe Xaa Xaa Xaa Xaa Xaa Asn 
1               5                   10                  15      


His Leu Xaa Xaa Xaa Ile Ile Trp Leu Xaa Xaa Xaa Xaa Met Xaa Xaa 
            20                  25                  30          


Xaa Xaa Xaa 
        35  


<210>  158
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P15 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (4)..(30)
<223>  Xaa is any amino acid

<400>  158

Leu Arg Cys Xaa Xaa Xaa Xaa Xaa Xaa Xaa Glu Asn Gly Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Met Trp Asn Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Ser Tyr 
            20                  25                  30          


Lys Asn Lys 
        35  


<210>  159
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P15 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(34)
<223>  Xaa is any amino acid

<400>  159

Xaa Xaa Xaa Xaa Thr Xaa His Tyr Asn Xaa Glu Asn Gly Ile Gly Asn 
1               5                   10                  15      


His Leu Met Xaa Asn Xaa Xaa Xaa Xaa Asn Xaa Gln Xaa Xaa Xaa Xaa 
            20                  25                  30          


Lys Xaa Lys 
        35  


<210>  160
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P15 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (2)..(35)
<223>  Xaa is any amino acid

<400>  160

Leu Xaa Cys Xaa Xaa Xaa His Xaa Asn Xaa Xaa Xaa Xaa Xaa Gly Asn 
1               5                   10                  15      


His Xaa Xaa Trp Xaa Xaa Xaa Trp Leu Xaa Xaa Xaa Xaa Met Ser Xaa 
            20                  25                  30          


Xaa Asn Xaa 
        35  


<210>  161
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P15 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(35)
<223>  Xaa is any amino acid

<400>  161

Xaa Arg Xaa Pro Xaa Pro His Xaa Xaa Phe Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Ile Ile Xaa Xaa Xaa Ala Xaa Gln Xaa Ser Tyr 
            20                  25                  30          


Xaa Xaa Xaa 
        35  


<210>  162
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P16 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (4)..(25)
<223>  Xaa is any amino acid

<400>  162

Ser Asn Arg Xaa Xaa Xaa Met Xaa Xaa Xaa Xaa Gly Leu Xaa Gly Pro 
1               5                   10                  15      


Xaa Xaa Ile Met Xaa Xaa Xaa Xaa Xaa 
            20                  25  


<210>  163
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P16 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(25)
<223>  Xaa is any amino acid

<400>  163

Xaa Xaa Xaa Xaa Phe Phe Met Xaa Xaa Xaa Xaa Xaa Xaa Cys Xaa Xaa 
1               5                   10                  15      


Phe Gly Xaa Xaa Xaa Xaa Lys Xaa Xaa 
            20                  25  


<210>  164
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P16 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (5)..(21)
<223>  Xaa is any amino acid

<400>  164

Ser Asn Arg Asp Xaa Xaa Xaa Xaa Xaa Ile Phe Gly Leu Xaa Gly Pro 
1               5                   10                  15      


Xaa Xaa Ile Met Xaa Arg Lys Arg Arg 
            20                  25  


<210>  165
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P16 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (2)..(25)
<223>  Xaa is any amino acid

<400>  165

Ser Xaa Xaa Xaa Xaa Xaa Xaa Val Asn Xaa Xaa Xaa Xaa Cys Xaa Xaa 
1               5                   10                  15      


Phe Gly Xaa Xaa Glu Xaa Xaa Xaa Xaa 
            20                  25  


<210>  166
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Group P16 variant AMP sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(23)
<223>  Xaa is any amino acid

<400>  166

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Val Asn Ile Phe Xaa Xaa Xaa Xaa Pro 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Arg Xaa Arg Arg 
            20                  25  


<210>  167
<211>  71
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  antimicrobial peptide

<400>  167

Lys Ser Lys Leu Ser Leu Lys Lys Gln Gly Thr Ile His Leu Asp Ala 
1               5                   10                  15      


Gln Ser Ser Cys Asp Val Met His Phe Pro Lys Cys Asp Leu Ala Pro 
            20                  25                  30          


Asn Val Gln Arg Gln Ala Trp Leu Phe Lys Val Ala Ser Lys Glu Ala 
        35                  40                  45              


Lys Glu Leu Arg Tyr Tyr Leu Leu Asn Pro Tyr Leu Asp Val Ser Ala 
    50                  55                  60                  


Arg Asn Val Gly Ser Lys Val 
65                  70      


<210>  168
<211>  47
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimicribial peptide

<400>  168

Lys Ala Gly Glu Gly Glu Arg Gly Glu Arg Glu Val Leu Asn His Gln 
1               5                   10                  15      


Lys Thr Ile Leu Glu Pro Ser Ser Cys Pro Leu Ile Ser Pro His Ser 
            20                  25                  30          


Thr Gly Leu Gly His Arg Pro Ser Leu Phe Arg Leu Thr Leu Ala 
        35                  40                  45          


<210>  169
<211>  42
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimircrobial Peptide

<400>  169

Leu Lys Gly Ile Lys Asn Ala Ala Gln Leu Leu Arg Phe Pro Pro Asn 
1               5                   10                  15      


Cys Lys Leu Cys Ser Cys Thr Val Phe Val His Lys Asp His Cys Val 
            20                  25                  30          


Val Gln Glu Ala Ser Gly Val Phe Arg Phe 
        35                  40          


<210>  170
<211>  47
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimicrobial Peptide

<400>  170

Asn Ala Ala Arg Asp His Ser Ala Thr Arg Cys Lys Gln Arg Ser Ala 
1               5                   10                  15      


Arg Leu Gln Ile Ala Ala Gln Asp Tyr Arg Ser Gln Arg Ser Ala Arg 
            20                  25                  30          


Leu Gln Ile Ala Thr Gln Arg Lys Ile Thr Asp Arg Asn Thr Ala 
        35                  40                  45          


<210>  171
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimicrobial Peptide

<400>  171

Leu Lys Pro Ser Asn Ile Gln Val Lys Leu Gln Tyr Ile Tyr Trp 
1               5                   10                  15  


<210>  172
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimicrobial peptide precursor

<400>  172

Met Asn Cys Gly Ser Phe Pro Cys Asp Ala Cys Asp Val Cys Glu Tyr 
1               5                   10                  15      


Val Asp Ala Lys Thr Lys Leu Lys Leu Pro Asn Gly Arg Trp His Ser 
            20                  25                  30          


Ile Gln Phe Arg Val Thr Cys Gln Thr Pro Gly Val Ile Tyr Leu Ala 
        35                  40                  45              


Gln Cys Leu Cys Gly Gly Phe Tyr Ile Gly Lys Thr Lys Arg Gln Phe 
    50                  55                  60                  


Phe Lys Arg Ile Arg Asp His Ile Lys Pro Ile Arg Lys Asn Lys Met 
65                  70                  75                  80  


Asp Thr Ala Ile Ser Arg His Val Gly Ile His His Asn Phe Asn Pro 
                85                  90                  95      


Gln Phe Ile Lys Phe Ser Ala Leu Glu His Ile Pro Gln Thr Leu Ala 
            100                 105                 110         


Val Ala Ala Leu Ile Ala Ser Cys Tyr Asn 
        115                 120         


<210>  173
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimicrobial peptide precursor

<400>  173

Met Glu Glu Ile Val Phe Pro Leu Gln His Pro Phe His Leu Asp Cys 
1               5                   10                  15      


Leu Phe Phe Leu Leu Arg His Leu Ser Trp Glu Lys Thr 
            20                  25                  


<210>  174
<211>  43
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimicrobial peptide precursor

<400>  174

Met Ser Ile Lys Lys Lys Glu Glu Met Ile Gln Val Lys Gly Met Leu 
1               5                   10                  15      


Lys Trp Lys Asn Asp Phe Tyr Gln Leu Leu Glu Arg Phe Ser Val Leu 
            20                  25                  30          


Cys Leu Glu Lys Asn Pro Glu Met Leu Lys Leu 
        35                  40              


<210>  175
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimicrobial peptide precursor

<400>  175

Met Ile Gln Val Lys Gly Met Leu Lys Trp Lys Asn Asp Phe Tyr Gln 
1               5                   10                  15      


Leu Leu Glu Arg Phe Ser Val Leu Cys Leu Glu Lys Asn Pro Glu Met 
            20                  25                  30          


Leu Lys Leu 
        35  


<210>  176
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimicrobial peptide precursor

<400>  176

Met Pro Lys Lys Lys Glu Glu Thr Ile Gln Met Lys Gly Met Leu Lys 
1               5                   10                  15      


Trp Lys Asn Asp Phe Phe Gln Leu Leu His Ala 
            20                  25          


<210>  177
<211>  41
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimicrobial peptide precursor

<400>  177

Met Ser Gly Ser Arg Ile Gly Leu Pro Leu Ala Leu Phe Pro Val Thr 
1               5                   10                  15      


Phe Val Lys Ile Ser Leu Phe Ile Leu Leu Ser Ser Ser Ser Ser Ala 
            20                  25                  30          


Phe Leu Leu Gly Glu His Ser Tyr Cys 
        35                  40      


<210>  178
<211>  85
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Antimicrobial peptide precursor

<400>  178

Met Ser Ser Pro Arg Arg Asp Ala Asn Glu Glu Glu Arg Arg Asp Asp 
1               5                   10                  15      


Pro Asp Glu Arg Asp Val Glu Val Glu Lys Arg Leu Leu Pro Val Thr 
            20                  25                  30          


Thr Ser Glu Asn Val Leu Val His Arg Gly Gly Gln Lys Ala Gly Met 
        35                  40                  45              


Asp His Arg Glu Val Thr Gln Gly Trp Arg Glu Asp Leu Gly His Gln 
    50                  55                  60                  


Glu Glu Leu Ser Leu Asn Leu Gln Glu Asn Asn Gly Gly His Pro Gln 
65                  70                  75                  80  


Phe Met Pro Phe Gln 
                85  


